Category Archives: PrEP

  1. France’s The Warning on Biomedical Prevention

    via The Warning (France) In France, the controversy between HIV organizations about PrEP appear in the media and social networks, from moral considerations disguised in ethical objections to classic behavioral speculations (as there was on the TasP or PEP) [4]. So, to clarify and defuse the situation, it should be noted some points : The biomedical prevention is a Read More >>

    Africa, condoms, HIV, hiv prevention, HIV transmission, HIV/AIDS, PLWHA, PrEP
  2. The road to PrEP: trials, regulation and roll-out

    via, by Gus Cairns Within the next three years, up to 33,000 people may take part in 22 different studies worldwide to demonstrate the feasibility, or otherwise, of pre-exposure prophylaxis (PrEP) to prevent HIV, the IAPAC evidence summit, Controlling the HIV epidemic with antiretrovirals, was told on 12 June.Some of these studies are underway but others Read More >>

    ARVs, hiv prevention, MSM, Partners PrEP, PrEP, Tenofovir, Truvada
  3. Meet Virginia – A Friendly Rectal Microbicide Advocate

    Check out this interesting mini-bio of Virginia Zalazar, the latest in IRMA’s “Meet a Friendly Rectal Microbicide Advocate” series on the IRMA website here.  Virginia is one of six new bios just posted a few days ago, including individuals from Kenya, Thailand, the UK, India and the US.  Each will be featured on the blog, and you can Read More >>

    AVAC, hiv prevention, HIV/AIDS, IRMA, Meet a Friendly Rectal Microbicide Advocate, Microbicides 2012, PrEP, rectal microbicide
  4. South African Clinicians Outline Best Treatment for Prevention Practices

    via, by Mia Malan South African guidelines for the preventative use of HIV medication by men who have sex with men who are not infected with the virus are to be published in the peer-reviewed academic publication, Southern African Journal of HIV Medicine, this month. The treatment, pre-exposure prophylaxis (Prep), consists of an antiretroviral (ARV) pill Read More >>

    Africa, ARV, HIV, hiv prevention, MSM, PrEP, South Africa, Tenofovir
  5. PrEP: time to rethink prevention, effectiveness and ethics?

    via Somatosphere, by Marsha Rosengarten One of the more controversial interventions proposed for HIV prevention in those who test HIV antibody negative and perceived to be at risk is pre-exposure prophylaxis (PrEP) – a daily pill comprising one or two antiretroviral drugs manufactured by Gilead Inc. Besides the mixed results from multi-site randomised controlled trials (RCTs) seeking Read More >>

    adherence, Bill and Melinda Gates Foundation, FEM-PrEP, Gilead, hiv prevention, iPrEx, pre-exposure prophylaxis, PrEP, Treatment as Prevention
  6. Characteristics Qualifying Gay Men for Intermittent PrEP

    via, by Michael Carter Older, better-educated gay men who use sexual networking sites and have sex outside the context of committed relationships may be appropriate targets for intermittent pre-exposure prophylaxis (PrEP), US research published in the online edition of the Journal of Acquired Immune Deficiency Syndromes suggests. The investigators found that individuals with this profile were Read More >>

    anal intercourse, antiretroviral therapy, gay men, HIV, hiv prevention, iPrEx, MSM, PrEP
  7. PrEP Provides New Hope for HIV Prevention in Nigeria

    via Leadership, by Winifred Ogbebo *Mentions IRMA advocate Morenike Ukpong!* Like a breath of fresh air, the news that a combination prevention drug would soon hit the Nigerian market is definitely something to cheer about, given Nigeria’s high prevalence of HIV rate, which is said to be second only to South Africa in the African continent. WINIFRED Read More >>

    Africa, HIV/AIDS. pre-exposure prophylaxis, Nigeria, pre-exposure prophylaxis, PrEP, South Africa, sub-saharan Africa, Truvada
  8. FDA Hearing on Truvada as PrEP – Watch the Webcast!

    On May 10, 2012 the FDA Antiviral Drug Advisory Committee strongly recommended that emtricitabine/tenofovir disoproxil fumarate (TDF/FTC or Truvada) be approved for use as pre-exposure prophylaxis (PrEP) among sexually active adult men and women – particularly gay men and other MSM, serodiscordant heterosexual couples, and other individuals at high risk. It is likely the FDA will follow Read More >>

    FDA, HIV/AIDS. pre-exposure prophylaxis, MSM, pre-exposure prophylaxis, PrEP, risk, Tenofovir, Truvada
  9. POZ: David Evans Gets Practical About PrEP

    [IRMA highly recommends this one. Brilliant, strategic, thoughtful, sober, forward-thinking – a must read] via POZ, by David Evans Excerpt: Give people the facts–the whole picture–and let them decide whether PrEP is right for them Let’s tell people how effective the drug is when they actually take it as prescribed–over 90 percent effective–and stop quoting statistics from Read More >>

    FDA, hiv prevention, HIV/AIDS policy, HIV/AIDS. pre-exposure prophylaxis, new prevention technologies, PrEP, Truvada
  10. Antiretroviral Prophylaxis for HIV Prevention Reaches a Key Milestone

    via, by Salim S Abdool Karim  and Quarraisha Abdool Karim On May 10, 2012, a US Food and Drug Administration (FDA) advisory committee voted in support of the use of tenofovir-emtricitabine for HIV prevention.1 If the FDA, which is scheduled to make its decision by June 15, adopts the committee’s recommendations, tenofovir-emtricitabine will become the first Read More >>

    antiretroviral therapy, ART, ARV, ARVs, FDA, FEM-PrEP, HIV, HIV/AIDS. pre-exposure prophylaxis, pre-exposure prophylaxis, PrEP, Salim S. Abdool Karim, Treatment, Treatment as Prevention, VOICE